HRID 409708As product
Completing data — refresh the page later to see the latest
1333390-56-9O=C(Nc1ccc(Cl)c(C(F)(F)F)c1)Nc1ccc(O)cc1FYNYHPPDKOFJEOD-UHFFFAOYSA-N1333390-56-9Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
UsesThe impurity 1-(4-chloro-3-(trifluoromethyl)phenyl)-3-(3-fluoro-4-hydroxyphenyl)urea is an impurity with the structure shown below that is generated during the production of regorafenib. Regorafenib is a novel multi-kinase inhibitor developed by Bayer AG. It targets tumorigenesis, tumor angiogenesis, and the maintenance of tumor microenvironment signaling by inhibiting multiple tumor-promoting protein kinases.